IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

Go back to IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, Offers Guidance

July 30, 2021 7:13 AM EDT

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $9.8 million versus the consensus estimate of $8.46 million.

GUIDANCE:

Iradimed Corp. sees Q3 2021 EPS of $0.16-$0.17, versus the consensus of... More